The results showed that after FOXO4-DRI treatment, the p-P53/P53 ratio significantly increased in the nucleus, cytoplasm, and total protein samples (Figure 5D)
Important safety warnings seek urgent medical attention if you experience: Severe or persistent abdominal pain, which may radiate to the back this could indicate pancreatitis , a serious but rare risk associated with GLP-1based therapies as a class [16] [17] Right upper quadrant pain, fever, or jaundice these may suggest gallbladder disease , another class-associated risk Signs of dehydration (dizziness, reduced urine output, extreme thirst) resulting from severe vomiting or diarrhoea, which can affect kidney function Pregnancy and breastfeeding: Use of GLP-1based therapies and related investigational agents is not recommended during pregnancy or breastfeeding
Testosterone connection: While CJC-1295 and ipamorelin do not directly stimulate testosterone production, the elevation in growth hormone and IGF-1 supports testosterone through several indirect mechanisms: Improved deep sleep quality (testosterone is primarily produced during deep sleep stages) Enhanced lipolysis and reduced visceral fat (less aromatase activity) Better recovery and cellular repair Improved insulin sensitivity Support for overall endocrine system function Clinical evidence: A study published in the Journal of Clinical Endocrinology & Metabolism found that CJC-1295 produced sustained increases in GH and IGF-1 levels in healthy adults (5)
If youre a Humana member with a drug plan, you can simply explore our list of covered drugs for Medicare
.webp)
